You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. High Power Density Dual Rotor Permanent Magnet Motor with Integrated Cooling and Drive for Aircraft Propulsion

    SBC: Advanced Magnet Lab, Inc.            Topic: 1

    There is a critical need for electrification of transportation systems. The proposed technology enables the development of very high-power density permanent magnet motors, which when coupled to an integrated SiC drive allows for an overall specific power beyond 12 kW/kg. The proposed concept relies on the tight integration of a high-power density dual-rotor permanent magnet motor, high power densi ...

    STTR Phase II 2020 Department of EnergyARPA-E
  2. High Power Density Dual Rotor Permanent Magnet Motor with Integrated Cooling and Drive for Aircraft Propulsion

    SBC: Advanced Magnet Lab, Inc.            Topic: 1

    There is a critical need for electrification of transportation systems. The proposed technology enables the development of very high-power density permanent magnet motors, which when coupled to an integrated SiC drive allows for an overall specific power beyond 12 kW/kg. The proposed concept relies on the tight integration of a high-power density dual-rotor permanent magnet motor, high power densi ...

    STTR Phase II 2020 Department of EnergyARPA-E
  3. High Power Density Dual Rotor Permanent Magnet Motor with Integrated Cooling and Drive for Aircraft Propulsion

    SBC: Advanced Magnet Lab, Inc.            Topic: 1

    There is a critical need for electrification of transportation systems. The proposed technology enables the development of very high-power density permanent magnet motors, which when coupled to an integrated SiC drive allows for an overall specific power beyond 12 kW/kg. The proposed concept relies on the tight integration of a high-power density dual-rotor permanent magnet motor, high power densi ...

    STTR Phase I 2020 Department of EnergyARPA-E
  4. Regenerative Therapy for Corneal Endothelial Dystrophies and Injuries

    SBC: RASHMIVU LLC            Topic: N

    Summary Worldwide, only 1 out of 70 patients with corneal endothelial dystrophies and injuries receive a corneal transplant due to the limited corneal donor pool, the need for advanced surgical facilities and talent, and expense. RashmiVu is developing a stem cell based regenerative technology that addresses this large unmet global need through a paradigm shift, wherein treatment could be as simpl ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  5. Development of a topical fixed-dose combination drug for peripheral neuropathic pain.

    SBC: WinSanTor, Inc.            Topic: NINDS

    PROJECT SUMMARY An estimated 30 million people in the United States suffer from some form of peripheral neuropathy, a condition that develops as a result of damage to the peripheral nervous system. The top two major causes of peripheral neuropathy in the US are diabetes mellitus (both T1DM and T2DM) and chemotherapeutic agents. Currently, there are no FDA-approved treatments to prevent or reverse ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  6. Developing and Testing the Opioid Rapid Response System

    SBC: Real Prevention LLC            Topic: NIDA

    The goal of this project is to prevent deaths from opioid overdoses through developing and commercializing the Opioid Rapid Response System (ORRS). This system is designed to reduce the cost of the opioid epidemic by developing standardized and effective procedures for recruiting and training citizen responders to use the PulsePoint app to administer life-saving naloxone/Narcan. This i-Corps suppl ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  7. Lead compound discovery from proprietary mycobacterial strains for treatment of PTSD

    SBC: MYCOBACTERIA THERAPEUTICS CORPORATION            Topic: NCCIH

    Project Summary Immunoregulation, i.e., balanced expression of regulatory and effector T cells, is thought to be compromised in modern high-income settings due in part to reduced contact with commensal and environmentally derived bacteria, also known as “old friends”. Failed immunoregulation is thought to be one factor contributing to recent increases in stress-related and chronic inflammatory ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  8. FES-Rowing: Preventing the Secondary Conditions of Paralysis Through Vigorous Exercise

    SBC: Myolyn, LLC            Topic: NICHD

    PROJECT SUMMARY/ABSTRACT Lack of exercise is a major cause of secondary health conditions, especially for people with paralysis, for whom participation in physical activity is especially difficult. Hybrid functional electrical stimulation (H- FES) exercise enables vigorous, total body physical activity for people with paralysis. However, existing H-FES devices are neither affordable nor accessible ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  9. Development of an irreversible covalent inhibitor of FMS-like tyrosine kinase receptor 3 for treating acute myeloid leukemia

    SBC: BRIDGENE BIOSCIENCES INC            Topic: 102

    PROJECT SUMMARY Acute myeloid leukemia (AML), a malignant disease of hematopoietic precursor cells in the bone marrow, is one of the most common cancers in adults accounting for 1% of all cancers. AML is typically diagnosed later in life with individuals 60 and older having a long-term survival rate of merely 5-15%. Cytogenic analysis of the abnormal cells at the time of diagnosis has proven to be ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  10. STING Activators as Therapy for Cancer

    SBC: STINGINN, LLC            Topic: 101

    PROJECT SUMMARY The ability of dying cells to activate antigen presenting cells (APCs) is carefully controlled to avoid unwarranted inflammatory responses. Thus, tumor cells avoid aggravating APCs by efficiently simulating regular dying cells which following phagocytosis do not trigger inflammatory responses required for efficient cytotoxic T lymphocyte (CTL) priming. However, dying tumor cells co ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government